ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,987Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 54

$595K Total Retail Price of All Prescriptions

Rank: 7 out of 54

408 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 408 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

13% of this provider’s 408 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,612 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
WARFARIN SODIUM 409 153 1 7
OMEPRAZOLE 404 277 2 4
LEVOTHYROXINE SODIUM 370 286 3 1
LISINOPRIL 370 313 3 2
SIMVASTATIN 312 251 5 3
GABAPENTIN 244 159 6 13
AMLODIPINE BESYLATE 233 212 7 6
FUROSEMIDE 228 179 8 5
HYDROCHLOROTHIAZIDE 224 195 9 14
HYDROCODONE-ACETAMINOPHEN 218 191 S3 10 8
RANITIDINE HCL 179 117 11 33
METFORMIN HCL 178 113 12 11
METOPROLOL SUCCINATE 176 153 13 20
POLYETHYLENE GLYCOL 3350 160 82 14 32
ATORVASTATIN CALCIUM 158 139 15 19
OXYCODONE HCL 158 79 S2 15 26
SERTRALINE HCL 155 94 17 21
TRAZODONE HCL 150 135 18 24
CITALOPRAM HBR 147 116 19 9
ATENOLOL 137 101 20 17
POTASSIUM CHLORIDE 135 69 21 12
METOPROLOL TARTRATE 135 127 21 10
MIRTAZAPINE 117 105 23 18
LOSARTAN POTASSIUM 114 113 24 16
TAMSULOSIN HCL 108 87 25 25
QUETIAPINE FUMARATE 103 86 26 30
FLUTICASONE PROPIONATE 102 70 27 37
RISPERIDONE 99 31 28 38
ALENDRONATE SODIUM 98 73 29 23
OXYBUTYNIN CHLORIDE 91 21 30 77
DONEPEZIL HCL 88 79 31 15
GLIPIZIDE 76 58 32 41
ZOLPIDEM TARTRATE 75 43 33 27
KETOCONAZOLE 71 16 34 125
LOVASTATIN 66 66 35 31
DIVALPROEX SODIUM 63 40 36 61
CARBIDOPA-LEVODOPA 63 51 36 42
HUMALOG 63 15 36 131
ADVAIR DISKUS 62 44 39 49
PAROXETINE HCL 60 54 40 52
TOPIRAMATE 60 0 40 163
LANTUS 59 21 42 39
CYMBALTA 57 32 43 46
BACLOFEN 55 0 44 65
MORPHINE SULFATE ER 52 25 S2 45 47
PREDNISONE 52 48 45 34
SEROQUEL 51 50 47 63
METHADONE HCL 51 11 S2 47 70
FLUOXETINE HCL 50 36 49 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.